Sign in
4

Changes in Ownership

Parabilis Medicines, Inc. Filed Acc 0001231919-26-000638

Director bought 21,188,750 shares at $20.00 ($423,775,000)

  • Director acquired 7,744,621 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
RA CAPITAL MANAGEMENT, L.P. Director 2026-06-11 Conversion +6,556,740 6,556,740 I
RA CAPITAL MANAGEMENT, L.P. Director 2026-06-11 Conversion +1,187,881 1,187,881 I
RA CAPITAL MANAGEMENT, L.P. Director 2026-06-11 Purchase +19,728,353 $20.00 $394,567,060 26,285,093 I
RA CAPITAL MANAGEMENT, L.P. Director 2026-06-11 Purchase +1,460,397 $20.00 $29,207,940 2,648,278 I
Derivatives
RA CAPITAL MANAGEMENT, L.P. Director 2026-06-11 Conversion · Series E Preferred Stock −642,250 0 I
RA CAPITAL MANAGEMENT, L.P. Director 2026-06-11 Conversion · Series E Preferred Stock −160,562 0 I
RA CAPITAL MANAGEMENT, L.P. Director 2026-06-11 Conversion · Series F Preferred Stock −9,445,363 0 I
RA CAPITAL MANAGEMENT, L.P. Director 2026-06-11 Conversion · Series F Preferred Stock −1,666,829 0 I
Open-market purchases · 21,188,750 sh · avg $20.00 · $423,775,000
Loading xslF345X06/form4-06152026_100639.xml…